Evaluating HFNO Versus NIV in Acute Respiratory Failure

Created using ChatSlide

The RENOVATE Trial is a pivotal study comparing the efficacy of High-Flow Nasal Oxygen (HFNO) to Non-Invasive Ventilation (NIV) in critical care settings. This multicentre trial assesses outcomes such as intubation rates and mortality over 28 and 90 days, ensuring rigorous participant demographic analysis. Primary findings indicate non-inferiority between HFNO and NIV, though limitations exist in subgroup sample sizes and patient comfort metrics. Despite serious adverse events noted, the...